Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2328128469', 'doi': 'https://doi.org/10.1016/j.juro.2012.02.1070', 'title': '971 SEMAPHORIN 3C PROMOTES SURVIVAL SIGNALING AND CASTRATION RESISTANT PROGRESSION IN PROSTATE CANCER', 'display_name': '971 SEMAPHORIN 3C PROMOTES SURVIVAL SIGNALING AND CASTRATION RESISTANT PROGRESSION IN PROSTATE CANCER', 'publication_year': 2012, 'publication_date': '2012-04-01', 'ids': {'openalex': 'https://openalex.org/W2328128469', 'doi': 'https://doi.org/10.1016/j.juro.2012.02.1070', 'mag': '2328128469'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.juro.2012.02.1070', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5042565610', 'display_name': 'Norihiro Hayashi', 'orcid': None}, 'institutions': [], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Norihiro Hayashi', 'raw_affiliation_strings': ['Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'Tokyo, Japan', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5015753910', 'display_name': 'Masaki Shiota', 'orcid': 'https://orcid.org/0000-0002-3306-4858'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Masaki Shiota', 'raw_affiliation_strings': ['Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Vancouver, Canada', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5034814953', 'display_name': 'Hidetoshi Kuruma', 'orcid': None}, 'institutions': [], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hidetoshi Kuruma', 'raw_affiliation_strings': ['Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'Tokyo, Japan', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5005297664', 'display_name': 'Shinichi Egawa', 'orcid': 'https://orcid.org/0000-0002-1115-4932'}, 'institutions': [], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Shin Egawa', 'raw_affiliation_strings': ['Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'Tokyo, Japan', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052720979', 'display_name': 'Christopher Ong', 'orcid': None}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Christopher Ong', 'raw_affiliation_strings': ['Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Vancouver, Canada', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5062125605', 'display_name': 'Martin Gleave', 'orcid': 'https://orcid.org/0000-0003-4235-0167'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Martin Gleave', 'raw_affiliation_strings': ['Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Vancouver, Canada', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 65}, 'biblio': {'volume': '187', 'issue': '4S', 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12061', 'display_name': 'Molecular Mechanisms of Axon Guidance', 'score': 0.9349, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12061', 'display_name': 'Molecular Mechanisms of Axon Guidance', 'score': 0.9349, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T13505', 'display_name': 'Apelin Signaling and Physiology', 'score': 0.9317, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/cell-signaling', 'display_name': 'Cell Signaling', 'score': 0.531995}, {'id': 'https://openalex.org/keywords/semaphorins', 'display_name': 'Semaphorins', 'score': 0.518421}], 'concepts': [{'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.8163842}, {'id': 'https://openalex.org/C132538176', 'wikidata': 'https://www.wikidata.org/wiki/Q24768287', 'display_name': 'Semaphorin', 'level': 3, 'score': 0.74548686}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.73886013}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.58609885}, {'id': 'https://openalex.org/C2780394083', 'wikidata': 'https://www.wikidata.org/wiki/Q539568', 'display_name': 'Angiogenesis', 'level': 2, 'score': 0.46484914}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.43135166}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.4132794}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.39101666}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.337048}, {'id': 'https://openalex.org/C74909509', 'wikidata': 'https://www.wikidata.org/wiki/Q10387', 'display_name': 'Gerontology', 'level': 1, 'score': 0.32820028}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.09771696}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.juro.2012.02.1070', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/2', 'display_name': 'Zero hunger', 'score': 0.56}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W256808345', 'https://openalex.org/W2497425234', 'https://openalex.org/W2131860275', 'https://openalex.org/W2130921030', 'https://openalex.org/W2055510343', 'https://openalex.org/W2010113284', 'https://openalex.org/W1970463288', 'https://openalex.org/W1968040844', 'https://openalex.org/W1539518942', 'https://openalex.org/W1488893964'], 'abstract_inverted_index': {'You': [0], 'have': [1], 'accessJournal': [2], 'of': [3, 122, 142, 186, 205, 241, 270, 284, 298, 393, 405, 447], 'UrologyProstate': [4], 'Cancer:': [5], 'Basic': [6], 'Research': [7], 'V1': [8], 'Apr': [9], '2012971': [10], 'SEMAPHORIN': [11], '3C': [12, 117], 'PROMOTES': [13], 'SURVIVAL': [14], 'SIGNALING': [15], 'AND': [16, 114], 'CASTRATION': [17], 'RESISTANT': [18], 'PROGRESSION': [19], 'IN': [20], 'PROSTATE': [21], 'CANCER': [22], 'Norihiro': [23, 36, 478], 'Hayashi,': [24], 'Masaki': [25, 47, 487], 'Shiota,': [26], 'Hidetoshi': [27, 58, 496], 'Kuruma,': [28], 'Shin': [29, 69, 505], 'Egawa,': [30], 'Christopher': [31, 80, 514], 'Ong,': [32], 'and': [33, 91, 132, 152, 172, 202, 211, 238, 253, 256, 266, 307, 337, 343, 352, 367, 370, 387, 398, 422, 436, 439, 456, 474], 'Martin': [34, 92, 523], 'Gleave': [35, 94, 524], 'HayashiNorihiro': [37], 'Hayashi': [38, 479], 'Tokyo,': [39, 61, 72, 480, 498, 507], 'Japan': [40, 62, 73, 481, 499, 508], 'More': [41, 52, 63, 74, 85, 97, 482, 491, 500, 509, 518, 527], 'articles': [42, 53, 64, 75, 86, 98, 483, 492, 501, 510, 519, 528], 'by': [43, 54, 65, 76, 87, 99, 156, 251, 259, 277, 373, 380, 412, 425, 451, 469, 484, 493, 502, 511, 520, 529], 'this': [44, 55, 66, 77, 88, 100, 485, 494, 503, 512, 521, 530], 'author': [45, 56, 67, 78, 89, 101, 486, 495, 504, 513, 522, 531], ',': [46, 57, 68, 79, 90], 'ShiotaMasaki': [48], 'Shiota': [49, 488], 'Vancouver,': [50, 83, 95, 489, 516, 525], 'Canada': [51, 84, 96, 490, 517, 526], 'KurumaHidetoshi': [59], 'Kuruma': [60, 497], 'EgawaShin': [70], 'Egawa': [71, 506], 'OngChristopher': [81], 'Ong': [82, 515], 'GleaveMartin': [93], 'View': [102], 'All': [103, 533], 'Author': [104], 'Informationhttps://doi.org/10.1016/j.juro.2012.02.1070AboutPDF': [105], 'ToolsAdd': [106], 'to': [107, 146, 198, 384, 433], 'favoritesDownload': [108], 'CitationsTrack': [109], 'CitationsPermissionsReprints': [110], 'ShareFacebookTwitterLinked': [111], 'InEmail': [112], 'INTRODUCTION': [113], 'OBJECTIVES': [115], 'Semaphorin': [116], '(SEMA3C),': [118], 'a': [119, 335, 442], 'secreted': [120], 'member': [121], 'the': [123, 139, 153, 183, 200, 271, 291, 427], 'semaphorin': [124], 'family,': [125], 'has': [126, 416], 'been': [127], 'implicated': [128], 'in': [129, 136, 188, 209, 212, 222, 290, 302, 324, 334, 340, 356], 'regulating': [130, 426], 'angiogenesis': [131], 'prostate': [133, 149], 'cancer': [134, 150, 303], 'invasion': [135], 'vitro.': [137], 'However,': [138], 'biological': [140], 'function': [141], 'SEMA3C': [143, 157, 165, 175, 187, 197, 206, 215, 242, 246, 285, 299, 328, 332, 347, 362, 381, 394, 406, 415, 430], 'on': [144, 419], 'progression': [145, 424], 'castration': [147], 'resistant': [148], '(CRPC)': [151], 'anti-tumor': [154], 'effect': [155, 283], 'silencing': [158, 240], 'are': [159, 177], 'still': [160], 'unknown.': [161], 'We': [162], 'found': [163], 'that': [164], 'expression': [166, 216, 333, 372], 'is': [167], 'up-regulated': [168], 'human': [169, 223], 'CRPC': [170, 293, 423], 'specimens': [171, 225], 'higher': [173, 301, 312], 'serum': [174, 218, 227, 313, 320], 'levels': [176, 219, 297, 314, 321], 'associated': [178], 'with': [179, 232, 309, 317, 326], 'CRPC.': [180, 236, 327, 448], 'To': [181], 'investigate': [182], 'functional': [184], 'activities': [185], 'CaP,': [189], 'we': [190], 'used': [191], 'an': [192], 'antisense': [193], 'oligonucleotide': [194], '(ASO)': [195], 'targeting': [196], 'assess': [199], 'potency': [201], 'anti-cancer': [203], 'activity': [204], 'ASO': [207, 286, 329, 348, 382], 'treatment': [208, 287, 349, 446], 'vitro': [210], 'vivo.': [213], 'METHODS': [214], 'or': [217, 226, 235], 'were': [220, 243, 300, 322], 'compared': [221], 'tissue': [224, 306], 'samples,': [228], 'respectively': [229], 'from': [230], 'patients': [231, 308, 325], 'BPH,': [233], 'CaP': [234, 310, 359, 420], 'Sequence-specific': [237], 'dose-dependent': [239, 338], 'assessed': [244, 276, 289], 'using': [245], 'ASO.': [247], 'Apoptosis': [248], 'was': [249, 275, 288, 409], 'quantified': [250], 'cleaved-PARP': [252], 'flow': [254, 264], 'cytometry,': [255], 'growth': [257, 355, 366, 397, 404, 434], 'rates': [258], 'direct': [260], 'viable': [261], 'cell': [262, 345, 354, 360, 365], 'counting,': [263], 'cytometry': [265], 'BrdU-incorporation': [267], 'assay.': [268], 'Activation': [269], 'EGFR-MAPK-SHC': [272, 428], 'survival': [273, 421], 'pathway': [274], 'Western': [278], 'blot': [279], 'analyses.': [280], 'In': [281, 377, 389], 'vivo': [282, 390], 'LNCaP': [292], 'model.': [294], 'RESULTS': [295], 'Expression': [296], 'than': [304, 315], 'normal': [305], 'had': [311], 'those': [316], 'BPH.': [318], 'Average': [319], 'highest': [323], 'potently': [330], 'inhibited': [331, 353, 411], 'sequence-specific': [336], 'manor': [339], 'LNCaP,': [341], 'C4-2': [342], 'DU145': [344], 'lines.': [346, 361], 'induced': [350], 'apoptosis': [351], 'all': [357], '3': [358], 'administration': [363], 'enhanced': [364], 'increased': [368], 'p-MAPK': [369], 'p-SHC': [371, 386], 'activating': [374], 'EGFR': [375], 'signaling.': [376], 'contrast,': [378], 'knockdown': [379, 392], 'led': [383, 432], 'decreased': [385], 'p-ERK1/2.': [388], 'ASO-mediated': [391], 'delayed': [395], 'tumor': [396], 'PSA': [399], 'increase': [400], 'after': [401], 'castration.': [402, 413], 'Conversely,': [403], 'overexpressing': [407], 'tumors': [408], 'not': [410], 'CONCLUSIONS': [414], 'multiple': [417], 'functions': [418], 'pathway.': [429], 'inhibition': [431], 'inhibitory': [435], 'apoptotic': [437], 'effects': [438], 'may': [440], 'be': [441], 'promising': [443], 'strategy': [444], 'for': [445], '©': [449], '2012': [450, 468], 'American': [452, 470], 'Urological': [453, 471], 'Association': [454, 472], 'Education': [455, 473], 'Research,': [457, 475], 'Inc.FiguresReferencesRelatedDetails': [458], 'Volume': [459], '187Issue': [460], '4SApril': [461], '2012Page:': [462], 'e395': [463], 'Advertisement': [464, 534, 535], 'Copyright': [465], '&': [466], 'Permissions©': [467], 'Inc.MetricsAuthor': [476], 'Information': [477], 'Expand': [532], 'PDF': [536], 'downloadLoading': [537], '...': [538]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2328128469', 'counts_by_year': [], 'updated_date': '2024-09-18T15:44:45.040532', 'created_date': '2016-06-24'}